Product analysis: the device remains implanted, therefore no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed that the valve sewing ring was damaged, likely due to explant procedure.All leaflets were in the closed position with gap between the left cusp and the other two leaflets.All leaflets were pliable.Abrasions resulting in holes were noted on the tunica of the right and non-coronary cusps.Abrasion noted on the left cusp approaching the left non-coronary commissure.Left right and non-coronary commissures appeared intact.The start of a commissure dehiscence observed on the left non-coronary commissure.A thick pannus remnant extended from the inflow margin of attachment of the left cusp.Radiography did not reveal calcification on the valve.Conclusions: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Pannus growth was confirmed on the valve.The host tissue growth may have impacted the normal function of the valve, contributing to leaflet damage when interacting with the pannus, and impaired shape of coaptation, resulting in dehiscence.H3: device evaluated? updated h6: coding updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|